Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost

Elizabeth Glaser Pediatric AIDS Foundation

Status: Completed

Conditions: AIDS; Antiretroviral Therapy; HIV; HIV Infections

Treatments: Behavioral: Intervention; Behavioral: Control

Study type: Observational

Funder types: Other

Identifiers

NCT01645865

RPC441

Details and patient eligibility

About

Although gains have been made in achieving the health-related Millennium Development Goals (MDG), much is still needed in countries affected by high levels of HIV/AIDS. Prevention of mother-to-child transmission (PMTCT) is a cornerstone strategy in reducing infant mortality from HIV. The study will employ a cluster randomized control trial (cRCT) with 26 health facilities randomized to two arms (intervention or control) to determine the effect of mobile phone technology on completion of key PMTCT milestones from antenatal to six weeks postpartum. The study will examine the acceptability, effectiveness, and cost of implementing a PMTCT-focused mHealth strategy among HIV-infected pregnant women, health workers, and male partners.

Enrollment: 600 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (female):

• HIV-positive pregnant women seeking ANC at a study site
• Up to 32 weeks gestation
• Own or have access to a mobile phone on which they can receive calls and SMS messages

Exclusion Criteria (female):

• HIV-positive pregnant women who have already initiated antiretroviral treatment

Inclusion Criteria (male):

• Referral by pregnant female partner

Trial design

600 participants in 2 patient groups

Control

Treatment:

Behavioral: Control

Intervention

Treatment:

Behavioral: Intervention